| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27K | — | — |
| R&D Expense | $6K | -68.4% | -96.2% |
| SG&A Expense | $4.6M | -76.7% | +67.2% |
| Operating Income | -$6.1M | +70.0% | -107.2% |
| Pre-tax Income | -$16.3M | +19.7% | -754.2% |
| Income Tax | -$765K | — | — |
| Net Income | -$15.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $109K | — | +34.6% |
| Current Assets | $15.0M | +399.6% | +1667.9% |
| Total Assets | $130.5M | +19.0% | +9104.1% |
| Current Liabilities | $125.6M | +11.0% | +7283.9% |
| Total Liabilities | $137.3M | +21.3% | +7973.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | — |
| Investing Cash Flow | $221K | — | — |
| Financing Cash Flow | $18.1M | — | — |
| -714.2% |
| EPS (Basic) | -$0.47 | +36.5% | -291.7% |
| EPS (Diluted) | -$0.47 | +36.5% | -291.7% |
| -$7.0M |
| -92.4% |
| -1618.3% |